Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice

L.F. van der Voort; A. Kok; A. Visser; C.B.M. Oudejans; M. Caldano; F. Gilli; A. Bertolotto; C.H. Polman; J. Killestein

doi:10.1177/1352458508096877

Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice

L.F. van der Voort, A. Kok, A. Visser, C.B.M. Oudejans, M. Caldano, F. Gilli, A. Bertolotto, C.H. Polman, J. Killestein

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	212-218
Journal	Multiple Sclerosis
Volume	15
Issue number	2
DOIs	https://doi.org/10.1177/1352458508096877
Publication status	Published - 2009

Access to Document

10.1177/1352458508096877

Cite this

@article{87a9901b798744f1a9cd3f87a632423f,

title = "Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice",

author = "{van der Voort}, L.F. and A. Kok and A. Visser and C.B.M. Oudejans and M. Caldano and F. Gilli and A. Bertolotto and C.H. Polman and J. Killestein",

year = "2009",

doi = "10.1177/1352458508096877",

language = "Undefined/Unknown",

volume = "15",

pages = "212--218",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice

AU - van der Voort, L.F.

AU - Kok, A.

AU - Visser, A.

AU - Oudejans, C.B.M.

AU - Caldano, M.

AU - Gilli, F.

AU - Bertolotto, A.

AU - Polman, C.H.

AU - Killestein, J.

PY - 2009

Y1 - 2009

U2 - 10.1177/1352458508096877

DO - 10.1177/1352458508096877

M3 - Article

C2 - 18805837

VL - 15

SP - 212

EP - 218

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 2

ER -